세계의 임상 화학 분석기 시장 규모 조사 및 예측 : 제품 유형별, 검사 유형별, 최종 사용자별, 지역별 분석(2023-2030년)

Global Clinical Chemistry Analyzer Market is valued at approximately USD 13.15 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.28% over the forecast period 2023-2030. A Clinical Chemistry Analyzer is a medical laboratory instrument used to analyze various chemical components in biological samples such as blood, serum, plasma, urine, and other bodily fluids. This type of analyzer is an essential tool in clinical chemistry, which is a branch of clinical pathology focused on studying the chemical composition of bodily fluids to aid in the diagnosis, treatment, and monitoring of diseases. The Clinical Chemistry Analyzer market is expanding because of factors such as rising geriatric population and increasing prevalence of chronic diseases.

The clinical chemistry analyzers conduct assays on samples such as blood, plasma, urine, and cerebrospinal fluid to find the presence of analytes linked to disease or medications. The global population is aging, particularly in developed countries. With aging, there is a higher susceptibility to chronic illnesses and a greater need for diagnostic tools such as clinical chemistry analyzers to monitor and manage these conditions effectively. According to a WHO document on ageing and health that was released in October 2021, around 1 in 6 people would be older than 60 by the year 2030. The same study predicts that 1.4 billion people, up from 1 billion in 2020, would be beyond the age of 60 by 2030. In addition, Clinical chemistry analyzers play a critical role in the evaluation of such chronic disorders by analyzing the lipids, electrolytes, plasma glucose levels, and other profiles of several components including blood, serum, plasma, and cerebrospinal fluid, among others. In turn, it is projected that the prevalence of chronic illnesses would increase, resulting in market growth. The GLOBOCAN 2020 report estimates that there were roughly 19,292,789 new cases of cancer worldwide in 2020. By 2040, there would likely be 28,887,940 instances, according to projections. Additionally, according to the IDF Diabetes Atlas Tenth Edition 2021, about 537 million adults worldwide were discovered to have diabetes in 2021, with estimates showing that figure wouldrise to 643 million by 2030 and 783 million by 2045. In addition, growing demand for point-of-care testing and rising technological advancements in clinical chemistry analyzers are some factors creating lucrative opportunities for the market. However, the high cost of clinical chemistry analyzers, the lack of trained and qualified professional's stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Chemistry Analyzer Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to factors such as rising disease prevalence, presence of key market players, increasing healthcare expenditure, rising investment for clinical development, and rising favorable government initiatives in the region. Whereas, Asia Pacific is projected to register significant growth owing to factors such as a rising geriatric population, rising prevalence of chronic diseases, and rising healthcare investments in the region.

Major market player included in this report are:

• Abbott Laboratories
• Danaher Corporation (Beckman Coulter, Inc.)
• Elitech Group
• F. Hoffmann-La Roche AG
• Horiba, Ltd.
• Johnson & Johnson Pvt Ltd
• Mindray Medical International Limited
• Siemens Healthcare Private Limited
• Sysmex Corporation
• Thermo Fisher Scientific Inc.

Recent Developments in the Market:

• In May 2022, Mindray unveiled the BS-600M, a powerful, efficient chemistry analyzer, to increase productivity, efficiency, and dependability in medium-volume laboratories.
• In April 2022, Sysmex Europe unveiled the XQ-320 XQ-Series Automated Haematology Analyzer as a brand-new three-part differential system. The XQ-320 uses trustworthy technology and a new level of use to give outstanding quality in a range of clinical laboratory applications.

Global Clinical Chemistry Analyzer Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Product, Types of Test, End user, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

• Analyzers
• Reagents
• Others

By Types of Type:

• Liver Panels
• Electrolyte Panels
• Thyroid Function Panels
• Lipid Profiles
• Others

By End User:

• Hospital
• Diagnostic Laboratories
• Academic Institutes
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Clinical Chemistry Analyzer Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Clinical Chemistry Analyzer Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Clinical Chemistry Analyzer Market, by Types of Tests, 2020-2030 (USD Billion)
  • 1.2.4. Clinical Chemistry Analyzer Market, by End User, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Clinical Chemistry Analyzer Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Clinical Chemistry Analyzer Market Dynamics

• 3.1. Clinical Chemistry Analyzer Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing geriatric population
    • 3.1.1.2. Increasing prevalence of chronic diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Clinical Chemistry Analyzer
    • 3.1.2.2. Lack of trained and qualified professionals
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing demand for point-of-care testing
    • 3.1.3.2. Rising technological advancements in clinical chemistry analyzer

Chapter 4. Global Clinical Chemistry Analyzer Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Clinical Chemistry Analyzer Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Clinical Chemistry Analyzer Market by Product, Performance - Potential Analysis
• 5.3. Global Clinical Chemistry Analyzer Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Clinical Chemistry Analyzer Market, Sub Segment Analysis
  • 5.4.1. Analyzers
  • 5.4.2. Reagents
  • 5.4.3. Others

Chapter 6. Global Clinical Chemistry Analyzer Market, by Types of Test

• 6.1. Market Snapshot
• 6.2. Global Clinical Chemistry Analyzer Market by Types of Test, Performance - Potential Analysis
• 6.3. Global Clinical Chemistry Analyzer Market Estimates & Forecasts by Types of Test 2020-2030 (USD Billion)
• 6.4. Clinical Chemistry Analyzer Market, Sub Segment Analysis
  • 6.4.1. Liver Panels
  • 6.4.2. Electrolyte Panels
  • 6.4.3. Thyroid Function Panels
  • 6.4.4. Lipid Profiles
  • 6.4.5. Others

Chapter 7. Global Clinical Chemistry Analyzer Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Clinical Chemistry Analyzer Market by End User, Performance - Potential Analysis
• 7.3. Global Clinical Chemistry Analyzer Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 7.4. Clinical Chemistry Analyzer Market, Sub Segment Analysis
  • 7.4.1. Hospital
  • 7.4.2. Diagnostic Laboratories
  • 7.4.3. Academic Institutes
  • 7.4.4. Others

Chapter 8. Global Clinical Chemistry Analyzer Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Clinical Chemistry Analyzer Market, Regional Market Snapshot
• 8.4. North America Clinical Chemistry Analyzer Market
  • 8.4.1. U.S. Clinical Chemistry Analyzer Market
    • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Types of Test breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Clinical Chemistry Analyzer Market
• 8.5. Europe Clinical Chemistry Analyzer Market Snapshot
  • 8.5.1. U.K. Clinical Chemistry Analyzer Market
  • 8.5.2. Germany Clinical Chemistry Analyzer Market
  • 8.5.3. France Clinical Chemistry Analyzer Market
  • 8.5.4. Spain Clinical Chemistry Analyzer Market
  • 8.5.5. Italy Clinical Chemistry Analyzer Market
  • 8.5.6. Rest of Europe Clinical Chemistry Analyzer Market
• 8.6. Asia-Pacific Clinical Chemistry Analyzer Market Snapshot
  • 8.6.1. China Clinical Chemistry Analyzer Market
  • 8.6.2. India Clinical Chemistry Analyzer Market
  • 8.6.3. Japan Clinical Chemistry Analyzer Market
  • 8.6.4. Australia Clinical Chemistry Analyzer Market
  • 8.6.5. South Korea Clinical Chemistry Analyzer Market
  • 8.6.6. Rest of Asia Pacific Clinical Chemistry Analyzer Market
• 8.7. Latin America Clinical Chemistry Analyzer Market Snapshot
  • 8.7.1. Brazil Clinical Chemistry Analyzer Market
  • 8.7.2. Mexico Clinical Chemistry Analyzer Market
• 8.8. Middle East & Africa Clinical Chemistry Analyzer Market
  • 8.8.1. Saudi Arabia Clinical Chemistry Analyzer Market
  • 8.8.2. South Africa Clinical Chemistry Analyzer Market
  • 8.8.3. Rest of Middle East & Africa Clinical Chemistry Analyzer Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Abbott Laboratories
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Danaher Corporation (Beckman Coulter, Inc.)
  • 9.3.3. Elitech Group
  • 9.3.4. F. Hoffmann-La Roche AG
  • 9.3.5. Horiba, Ltd.
  • 9.3.6. Johnson & Johnson Pvt Ltd.
  • 9.3.7. Mindray Medical International Limited
  • 9.3.8. Siemens Healthcare Private Limited
  • 9.3.9. Sysmex Corporation
  • 9.3.10. Thermo Fisher Scientific Inc.

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption